Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02489539 · ClinicalTrials.gov registry record · NA
Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms
A NA study of Aortic Aneurysm, Abdominal, sponsored by W.L.Gore & Associates.
- Active
- Registry status
- NA
- Development phase
- 175
- Enrollment target
- 20
- Study locations
NCT02489539 is a NA study of Aortic Aneurysm, Abdominal that is active but no longer recruiting, run by W.L.Gore & Associates. The registered enrollment target is 175 participants, above the 133-participant average among 8 other Aortic Aneurysm, Abdominal trials with a reported enrollment target (32% higher). The trial reports 20 study locations across 10 states.
The verdict
NCT02489539, a NA study of Aortic Aneurysm, Abdominal, is active but no longer recruiting, sponsored by W.L.Gore & Associates.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the study is to assess the safety and effectiveness of the GORE® EXCLUDER® Conformable AAA Endoprosthesis to treat an infrarenal aneurysm located in the abdominal aorta. Performance of the GORE® EXCLUDER® Conformable AAA Endoprosthesis will be judged by separate performance goals.
Conditions Studied
Interventions
- DEVICE GORE® EXCLUDER® Conformable AAA Endoprosthesis
Study Locations (20)
Florida
- River City Clinical Research - Jacksonville
- Baptist Cardiac and Vascular Institute - Miami
- Florida Hospital - Orlando
- Sarasota Vascular Specialists - Sarasota
Minnesota
- Essentia Institute of Rural Health - Duluth
- Minneapolis Heart Institute Foundation - Abbott Northwestern Hospital - Minneapolis
- Minneapolis Radiology and Vascular Research Foundation - Plymouth
- Mayo Clinic - Rochester - Rochester
California
- University of Southern California - Los Angeles
- Leland Stanford Junior University - Stanford
Georgia
- Emory University - Atlanta
- Vascular Surgical Associates, PC - Marietta
Illinois
- Loyola University - Chicago - Maywood
- Southern Illinois University - Springfield
Michigan
- University of Michigan - Ann Arbor
- Spectrum Health System - Grand Rapids
Alabama
- University of Alabama at Birmingham - Birmingham
Arizona
- Mayo Clinic Arizona - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2017-12-19 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02489539
The ClinicalTrials.gov registry entry for NCT02489539 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 133-participant average among 8 other Aortic Aneurysm, Abdominal trials with a reported enrollment target (32% higher). The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aortic Aneurysm, Abdominal appearing as the primary indexed condition, and to 1 intervention - of which GORE® EXCLUDER® Conformable AAA Endoprosthesis is the first listed.
NCT02489539 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Florida, Minnesota, California.
Frequently Asked Questions
What is clinical trial NCT02489539 about?
NCT02489539 is a clinical study titled "Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms". The purpose of the study is to assess the safety and effectiveness of the GORE® EXCLUDER® Conformable AAA Endoprosthesis to treat an infrarenal aneurysm located in the abdominal aorta. Performance of the GORE® EXCLUDER® Conformable AAA Endoprosthesis will be judged by separate performance goals.
What is the current status of trial NCT02489539?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 175 participants. The study started on 2017-12-19. Estimated completion is 2027-12-31.
What conditions does trial NCT02489539 study?
This clinical trial studies the following conditions: Aortic Aneurysm, Abdominal.
What interventions are being tested in trial NCT02489539?
The interventions under investigation include: GORE® EXCLUDER® Conformable AAA Endoprosthesis (DEVICE).
Who is sponsoring clinical trial NCT02489539?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02489539 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Aneurysm, Abdominal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
RECRUITING · NA
-
Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck
RECRUITING · NA
-
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion
RECRUITING · NA
-
Zenith® Fenestrated+ Clinical Study
RECRUITING · NA
-
Post-Approval Trial of the Talent™ Abdominal Stent Graft to Treat Aortic Aneurysms
COMPLETED · NA
-
Clinical Outcomes of Patients Treated With Open Surgical Repair for Complex Aortic Aneurysms
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.